Antioxidant Role of Vitamin E in Atherogenesis induced by Hyperfibrinogenemia

pp 405-410

Authors

  • Candelaria Llorens Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Becaria MYNCYT
  • María del Carmen Báez Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Instituto de Investigación en Ciencias de la Salud Humana (IICSHUM), Universidad Nacional de La Rioja
  • Mariana Tarán Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Becaria SECYT, Universidad Nacional de Córdoba
  • Vilma Campana Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Cátedra de Física Biomédica, Universidad Nacional de La Rioja
  • Ismael Fonseca II Cátedra de Anatomía Patológica, Universidad Nacional de Córdoba
  • Elsa Loyola II Cátedra de Anatomía Patológica, Universidad Nacional de Córdoba
  • José Palma Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba
  • Mónica Moya Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Cátedra de Física Biomédica, Universidad Nacional de La RiojaCórdoba,

DOI:

https://doi.org/10.7775/rac.v78i5.1943

Keywords:

Hyperfibrinogenemia, Atherogenesis, Oxidative stress, Superoxide dismutase, Vitamin E

Abstract

We used an experimental model of atherogenesis to evaluate the effect of vitamin E on oxidative stress induced by hyperfi-
brinogenemia (HF) and the possible normalization of oxidative stress markers. The following variables were studied: nitric oxide (NO), L-citrulline, superoxide dismutase (SOD) activity and regression of histopathological lesions in the thoracic aorta. The study was performed in 36 Wistar rats that were divided into three groups of 12 rats each: A, control group; B, HF for 90 days; C, HF for 90 days + vitamin E. Hyperfibrinogenemia was induced by the injection of epinephrine (0.1 ml/day/rat) during 90 days. The dose of vitamin E was 2 mg/day/rat during 75 days. We measured the plasma levels of fibrinogen (mg/dl), NO (uM) and L-citrulline (mM); SOD activity (U/ml) was assayed in red cell lysates using spectrophotometry. The histopathological sections of the thoracic aorta were examined using light micros- copy (LM). Statistical analysis was performed using MANOVA and Fisher’s test; a p value <0.05 was considered statistically significant. Rats in group B had a significant increase in fibrinogen levels B (407±8.9 mg/dl) compared to groups A (203±9 mg/dl) and C (191.58±17.79 mg/dl) (p<0.001). We observed a significant decrease in NO in group B (13.73±1.76 uM) versus groups A (23.58±0.08 uM) and C (26.64±3.65 uM) (p<0.001). L-citrulline increased significantly in groups B (4.99±0.18 mM) and C (6.60±0.16 mM) compared to group A (3.03±0.13 mM) (p<0.001). SOD activity was greater in groups B (251.67±10.34 U/ml) and C (304.75±10.43 U/ml) versus group A (139.44±4.74 U/ml) (p<0.001). Light microscopic examination revealed the presence of endothelial denudation, intimal thickening and vessel wall protrusion in group B (90%), while recovery of endothelial denudation and a 50% reduction in intimal thickening was observed in group C (p<0.001). High SOD activity might be insufficient to prevent abnormalities in the oxidative stress pathway induced by HF. Vitamin E would stop the chain reaction initiated by free radicals and thus decrease the superoxide anion, stimulating the bioavailability of NO with normalization of fibrinogen plasma levels.

Published

2025-10-28

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)